This effect could be explained by correlating the concentration of shed MSLN in the blood and in the ECS of A431/H9 tumor, as estimated in previous studies [8, 22, 23], similarly to that of 64Cu-NOTA-amatuximab. This evidence concerns the gene MSLN and neoplasm.